Literature DB >> 2149344

Remarkable activities of nucleoside triphosphate hydrolase in the tachyzoites of both virulent and avirulent strains of Toxoplasma gondii.

T Asai1, Y Suzuki.   

Abstract

Dithiothreitol-dependent MgATP2- and Mg-ADP- hydrolytic activities owing to nucleoside triphosphate hydrolase were examined kinetically in tachyzoite cells of five strains of Toxoplasma gondii with various virulence. The tachyzoites of all the strains were revealed to have a high ATP and ADP hydrolytic potency. The value of Vmax and Km obtained from each strain indicated that there were two classified types of T. gondii about ATP and ADP hydrolysis. The most virulent strain (RH) and avirulent strain (Fukaya) were classified in a type with higher ATPase than ADPase activities. Two virulent strains (C56, Beverley) and an avirulent strain (ME49) were classified in the other type with the same activities of ATPase and ADPase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2149344     DOI: 10.1016/0378-1097(90)90350-y

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  3 in total

1.  High correlation in antibody titers between the Sabin-Feldman dye test and an enzyme-linked immunosorbent assay detecting immunoglobulin G antibodies to the nucleoside triphosphate hydrolase of Toxoplasma gondii.

Authors:  T Asai; F Mizuno; S Kojima; T Takeuchi; A Kobayashi; Y Suzuki
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

2.  A novel GDP-dependent pyruvate kinase isozyme from Toxoplasma gondii localizes to both the apicoplast and the mitochondrion.

Authors:  Tomoya Saito; Manami Nishi; Muoy I Lim; Bo Wu; Takuya Maeda; Hisayuki Hashimoto; Tsutomu Takeuchi; David S Roos; Takashi Asai
Journal:  J Biol Chem       Date:  2008-03-06       Impact factor: 5.157

3.  Human platelet inhibition of Toxoplasma gondii growth.

Authors:  B F Chumpitazi; J Simon; B Polack; F Peyron; S Picot; J Ricard; P Ambroise-Thomas
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.